Wissenschaftliche Publikationen von GSASA-Mitgliedern 2014

Folgende wissenschftlichen Arbeiten wurden von GSASA-Mitgliedern in verschiedenen internationalen Zeitschriften publiziert. Klicken auf den jeweiligen Titel öffnet das entsprecende Abstract.


Prospective risk assessment and incident reporting for better pharmaceutical care at paediatric hospital discharge

Kaestli LZ, Cingria L, Fonzo-Christe C, Bonnabry P
Int J Clin Pharm 2014 doi : 10.1007/s11096-014-9977-y4

Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns

Fonzo-Christe C, Guignard B, Zaugg C, Coehlo A, Posfay-Barbe KM, Gervaix A, Desmeules J, Rollason V, Combescure C, Corbelli R, Rimensberger P, Pfister R, Bonnabry P.
Ther Drug Monit 2014 doi: 10.1097/FTD.0000000000000071

Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU

Pierre Voirol, Markoulina Berger-Gryllaki, André Pannatier, Philippe Eggimann, Farshid Sadeghipour
Eur J Hosp Pharm (2014) doi: 10.1136/ejhpharm-2014-000478

Effective treatment of invasive aspergillus fumigatus infection using combinations of topical and systemic antifungals in a severely burned patient

Anne Fournier, Olivier Pantet, Samia Guerid, Philippe Eggimann, Jean-Luc Pagani, Jean-Pierre Revelly, Philippe M. Hauser, Oscar Marchetti, Sara Fontanella, Igor Letovanec, François Ravat, Mette M. Berger, André Pannatier, Pierre Voirol, Yok-Ai Que
J Burn Care Res 2014 doi: 10.1097/BCR.0000000000000143

Impact of pharmaceutical care on self-administration of outpatient low-molecular-weight heparin therapy

Seraina Mengiardi, Dimitrios A. Tsakiris, Viviane Molnar, Urs Kohlhaas-Styk, Michael Mittag, Stephan Kraehenbuehl, Kurt E. Hersberger
Pharmacology & Pharmacy. 2014; 5:372-85 http://dx.doi.org/10.4236/pp.2014.54045


Adverse Drug Event Nonrecognition in Emergency Departments: An Exploratory Study on Factors Related to Patients and Drugs

Roulet L, Ballereau F, Hardouin JB, Chiffoleau A, Potel G, Asseray N
J Emerg Med. 2014 doi : 10.1016/j.jemermed.2013.11.124

Establishing a pharmacy presence in the emergency department: opportunities and challenges in the French setting

Roulet L, Asseray N, Ballereau F
Int J Clin Pharm. 2014;36(3):471-5 doi : 10.1007/s11096-014-9934-9

Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft: Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand

U. Winterfeld, V. Gotta, L.E. Rothuizen, A. Panchaud, A.O. Rossetti T. Buclin
Nervenarzt 2014 doi: 10.1007/s00115-014-4091-x

Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique

Alice Panchaud, Etienne Weisskopf , Ursula Winterfeld, David Baud, Monia Guidi, Chin Bin Eap, Chantal Csajka et Nicolas Widmer
Thérapie, 2014 doi:10.2515/therapie/2014026

Nanomedicines: addressing the scientific and regulatory gap

Tinkle S, McNeil SE, Mühlebach S, Bawa R, Borchard G, Barenholz YC, Tamarkin L, Desai N.
Ann N Y Acad Sci. doi: 10.1111/nyas.12403

First Asia-Pacific educational workshop on non-biological complex drugs (NBCDs), Kuala Lumpur, Malaysia, 8 October 2013

Philip D Walson,Stefan Mühlebach, Beat Flühmann
Generics and Biosimilars Initiative doi: 10.5639/gabij.2014.0301.010

Different pharmaceutical products need similar terminology

Crommelin DJ, de Vlieger JS, Weinstein V, Mühlebach S, Shah VP, Schellekens H.
AAPS J. 2014 Jan;16(1):11-4 doi: 10.1208/s12248-013-9532-0

How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider

Schellekens H, Stegemann S, Weinstein V, de Vlieger JS, Flühmann B, Mühlebach S, Gaspar R, Shah VP, Crommelin DJ
AAPS J. 2014 Jan;16(1):15-21 doi: 10.1208/s12248-013-9533-z

Trace element monitoring in the ICU: quality and economic impact of a change in sampling practice

Gagnon Ghislaine, Voirol Pierre, Soguel Ludivine, Boulat Olivier, Berger Mette M
Clin Nutr. 2014 pii: S0261-5614(14)00120-4. doi: 10.1016/j.clnu.2014.04.012

Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide

Humbert-Delaloye, V., Berger-Gryllaki, M., Voirol, P., Testa, B., Pannatier, A.
Eur J Hosp Phar doi:10.1136/ejhpharm-2013-000431


Development of ready-to-use cefuroxime syringes for use in ophtalmology

Sandrine Fleury-Souverain, Farshid Sadeghipour, Pascal Bonnabry
Eur J Hosp Pharm 2014; 21:34-38 DOI 10.1007/s11096-014-9977-y

A survey-based inventory of clinical decision support systems in computerised provider order entry in Swiss hospitals

Delphine Carli-Ghabarou, Hanna M Seidling, Pascal Bonnabry, Christian Lovis
Swiss Med Wkly 2013;143:w13894 doi: 10.4414/smw.2013.13894

Medication use in pregnancy: a cross-sectional, multinational web-based study

A Lupattelli, O Spigset, M J Twigg, K Zagorodnikova, A C Mårdby, M E Moretti, M Drozd, A Panchaud, K Hämeen-Anttila, A Rieutord, R Gjergja Juraski, M Odalovic, D Kennedy, G Rudolf, H Juch, A Passier, I Björnsdóttir, H Nordeng
BMJ Open 2014;4: e004365. doi:10.1136/ bmjopen-2013-004365

Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey

Chantal Csajka, Aurélie Jaquet, Ursula Winterfeld, Yvonne Meyer, Adrienne Einarson, Alice Panchaud
Swiss Medical Weekly 2014 doi:10.4414/smw.2014.13936